Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Alirocumab","url":"https:\/\/www.ortaakarsu.net\/?page_id=12319","facts":[{"label":"Active ingredient \/ generic name","value":"alirocumab"},{"label":"ATC code","value":"C10AX14"}]},{"title":"Inclisiran","url":"https:\/\/www.ortaakarsu.net\/?page_id=12373","facts":[{"label":"Active ingredient \/ generic name","value":"inclisiran"},{"label":"ATC code","value":"C10AX16"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"Current document checked 2026-11-02; revision date not printed; 4.2 Treatment transition from monoclonal antibody PCSK9 inhibitors"}],"sources":[{"label":"Leqvio \u2014 EMA product information","url":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/leqvio-epar-product-information_en.pdf"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:28744","available":true}}